{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:32:41Z","timestamp":1782189161493,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.7759\/cureus.87208","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:51:22Z","timestamp":1751529082000},"source":"Crossref","is-referenced-by-count":2,"title":["The Efficacy and Safety of Use of Cannabis and Cannabinoid Products for Pain Relief in Orthopaedic Conditions and Trauma"],"prefix":"10.7759","author":[{"given":"Dhruvil","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Murhekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrikant","family":"Sagane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashvin","family":"Pahwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos T","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, et al.. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380:2163-96. 10.1016\/S0140-6736(12)61729-2","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204428","article-title":"The global burden of low back pain: estimates from the Global Burden of Disease 2010 study","volume":"73","author":"Hoy D","year":"2014","unstructured":"Hoy D, March L, Brooks P, et al.. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014, 73:968-74. 10.1136\/annrheumdis-2013-204428","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/gnw002","article-title":"Musculoskeletal health conditions represent a global threat to healthy aging: a report for the 2015 World Health Organization World Report on ageing and health","volume":"56","author":"Briggs AM","year":"2016","unstructured":"Briggs AM, Cross MJ, Hoy DG, S\u00e0nchez-Riera L, Blyth FM, Woolf AD, March L. Musculoskeletal health conditions represent a global threat to healthy aging: a report for the 2015 World Health Organization World Report on ageing and health. Gerontologist. 2016, 56:S243-55. 10.1093\/geront\/gnw002","journal-title":"Gerontologist"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067545","article-title":"Health economic impact of moderate-to-severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data","volume":"13","author":"Coates G","year":"2023","unstructured":"Coates G, Clewes P, Lohan C, et al.. Health economic impact of moderate-to-severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data. BMJ Open. 2023, 13:e067545. 10.1136\/bmjopen-2022-067545","journal-title":"BMJ Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-11-6","article-title":"Bio-psychosocial determinants of time lost from work following non life threatening acute orthopaedic trauma","volume":"11","author":"Clay FJ","year":"2010","unstructured":"Clay FJ, Newstead SV, Watson WL, Ozanne-Smith J, McClure RJ. Bio-psychosocial determinants of time lost from work following non life threatening acute orthopaedic trauma. BMC Musculoskelet Disord. 2010, 11:6. 10.1186\/1471-2474-11-6","journal-title":"BMC Musculoskelet Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/BF02715690","article-title":"The natural history of rheumatoid arthritis: a fifteen year follow-up study. The prognostic significance of features noted in the first year","volume":"3","author":"Rasker JJ","year":"1984","unstructured":"Rasker JJ, Cosh JA. The natural history of rheumatoid arthritis: a fifteen year follow-up study. The prognostic significance of features noted in the first year. Clin Rheumatol. 1984, 3:11-20. 10.1007\/BF02715690","journal-title":"Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2307\/1220524","article-title":"A practical and natural taxonomy for cannabis","volume":"25","author":"Small E","year":"1976","unstructured":"Small E, Cronquist, et al.. A practical and natural taxonomy for cannabis. Taxon. 1976, 25:405-35. 10.2307\/1220524","journal-title":"Taxon"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agu052.58","article-title":"Global epidemiology of cannabis use and implications for public health","volume":"49","author":"Poznyak V","year":"2014","unstructured":"Poznyak V . Global epidemiology of cannabis use and implications for public health. Alcohol and Alcoholism. 2014, 49:i14. 10.1093\/alcalc\/agu052.58","journal-title":"Alcohol and Alcoholism"},{"key":"ref9","article-title":"Final act of the United Nations Conference for the adoption of a single convention on narcotic drugs","author":"United Nations","year":"1961","unstructured":"United Nations. Final act of the United Nations Conference for the adoption of a single convention on narcotic drugs. 1961."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/15563316221097698","article-title":"Public perceptions of opioid use following orthopedic surgery: a survey","volume":"18","author":"Alexander McIntyre J","year":"2022","unstructured":"Alexander McIntyre J, Pagani N, Van Schuyver P, Puzzitiello R, Moverman M, Menendez M, Kavolus J. Public perceptions of opioid use following orthopedic surgery: a survey. HSS J. 2022, 18:328-37. 10.1177\/15563316221097698","journal-title":"HSS J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-022-00465-y","article-title":"Cannabinoids as a potential alternative to opioids in the management of various pain subtypes: benefits, limitations, and risks","volume":"12","author":"Ang SP","year":"2023","unstructured":"Ang SP, Sidharthan S, Lai W, et al.. Cannabinoids as a potential alternative to opioids in the management of various pain subtypes: benefits, limitations, and risks. Pain Ther. 2023, 12:355-75. 10.1007\/s40122-022-00465-y","journal-title":"Pain Ther"},{"key":"ref12","article-title":"Evidence on strategies for addressing the opioid epidemic","author":"Phillips JK","year":"2017","unstructured":"Phillips JK, Ford MA, Bonnie RJ, et al.. Evidence on strategies for addressing the opioid epidemic. National Academies Press, Washington (DC); 2017."},{"key":"ref13","unstructured":"Drug overdose deaths. facts and figures. (2024). Accessed: 21 May 2025: https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates."},{"key":"ref14","unstructured":"Current UK data on opioid misuse. (Faculty of pain medicine. Current UK data on opioid misuse. Faculty of). Accessed. 6 June 2025: https:\/\/fpm.ac.uk\/opioids-aware-clinical-use-opioids\/current-uk-data-opioid-misuse."},{"key":"ref15","unstructured":"Deaths related to drug poisoning in England and Wales. 2018 registrations. (2018). Accessed: 21 May 2025: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpois...."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.51","article-title":"Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis","volume":"42","author":"Nielsen S","year":"2017","unstructured":"Nielsen S, Sabioni P, Trigo JM, et al.. Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis. Neuropsychopharmacology. 2017, 42:1752-65. 10.1038\/npp.2017.51","journal-title":"Neuropsychopharmacology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1089\/can.2017.0017","article-title":"Cannabis and pain: a clinical review","volume":"2","author":"Hill KP","year":"2017","unstructured":"Hill KP, Palastro MD, Johnson B, Ditre JW. Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2017, 2:96-104. 10.1089\/can.2017.0017","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2022.2060431","article-title":"Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States","volume":"43","author":"Wadsworth E","year":"2022","unstructured":"Wadsworth E, Hines LA, Hammond D. Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States. Subst Abus. 2022, 43:943-8. 10.1080\/08897077.2022.2060431","journal-title":"Subst Abus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2013.03.018","article-title":"The epidemiology and impact of pain in osteoarthritis","volume":"21","author":"Neogi T","year":"2013","unstructured":"Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013, 21:1145-53. 10.1016\/j.joca.2013.03.018","journal-title":"Osteoarthritis Cartilage"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304747","article-title":"The Global Burden of musculoskeletal pain - where to from here?","volume":"109","author":"Blyth FM","year":"2019","unstructured":"Blyth FM, Briggs AM, Schneider CH, Hoy DG, March LM. The Global Burden of musculoskeletal pain - where to from here?. Am J Public Health. 2019, 109:35-40. 10.2105\/AJPH.2018.304747","journal-title":"Am J Public Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7303.13","article-title":"Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review","volume":"323","author":"Campbell FA","year":"2001","unstructured":"Campbell FA, Tram\u00e8r MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ. 2001, 323:13. 10.1136\/bmj.323.7303.13","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2014.02.005","article-title":"The effects of cannabinoid administration on sleep: a systematic review of human studies","volume":"18","author":"Gates PJ","year":"2014","unstructured":"Gates PJ, Albertella L, Copeland J. The effects of cannabinoid administration on sleep: a systematic review of human studies. Sleep Med Rev. 2014, 18:477-87. 10.1016\/j.smrv.2014.02.005","journal-title":"Sleep Med Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2008.00917.x","article-title":"Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis","volume":"17","author":"Machado Rocha FC","year":"2008","unstructured":"Machado Rocha FC, St\u00e9fano SC, De C\u00e1ssia Haiek R, Rosa Oliveira LM, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl). 2008, 17:431-43. 10.1111\/j.1365-2354.2008.00917.x","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7303.16","article-title":"Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review","volume":"323","author":"Tram\u00e8r MR","year":"2001","unstructured":"Tram\u00e8r MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001, 323:16-21. 10.1136\/bmj.323.7303.16","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials","volume":"72","author":"Lynch ME","year":"2011","unstructured":"Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011, 72:735-44. 10.1111\/j.1365-2125.2011.03970.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(80)35258-5","article-title":"Effect of marihuana on intraocular and blood pressure in glaucoma","volume":"87","author":"Merritt JC","year":"1980","unstructured":"Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology. 1980, 87:222-8. 10.1016\/s0161-6420(80)35258-5","journal-title":"Ophthalmology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200420085712","article-title":"The therapeutic potential and usage patterns of cannabinoids in people with spinal cord injuries: a systematic review","volume":"19","author":"Nabata KJ","year":"2021","unstructured":"Nabata KJ, Tse EK, Nightingale TE, et al.. The therapeutic potential and usage patterns of cannabinoids in people with spinal cord injuries: a systematic review. Curr Neuropharmacol. 2021, 19:402-32. 10.2174\/1570159X18666200420085712","journal-title":"Curr Neuropharmacol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002266","article-title":"International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management","volume":"162","author":"Haroutounian S","year":"2021","unstructured":"Haroutounian S, Arendt-Nielsen L, Belton J, et al.. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain. 2021, 162:S117-24. 10.1097\/j.pain.0000000000002266","journal-title":"Pain"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-021-02205-y","article-title":"Cannabinoids and orthopedic surgery: a systematic review of therapeutic studies","volume":"16","author":"Vivace BJ","year":"2021","unstructured":"Vivace BJ, Sanders AN, Glassman SD, Carreon LY, Laratta JL, Gum JL. Cannabinoids and orthopedic surgery: a systematic review of therapeutic studies. J Orthop Surg Res. 2021, 16:57. 10.1186\/s13018-021-02205-y","journal-title":"J Orthop Surg Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1503\/cjs.001018","article-title":"Cannabis for pain in orthopedics: a systematic review focusing on study methodology","volume":"62","author":"Madden K","year":"2019","unstructured":"Madden K, George A, van der Hoek NJ, Borim FM, Mammen G, Bhandari M. Cannabis for pain in orthopedics: a systematic review focusing on study methodology. Can J Surg. 2019, 62:369-80. 10.1503\/cjs.001018","journal-title":"Can J Surg"},{"key":"ref31","article-title":"","author":"Huecker MR","year":"2023","unstructured":"Huecker MR, Azadfard M, Leaming JM, et al.. Opioid Addiction. StatPearls Publishing, Treasure Island, FL; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448203\/.."},{"key":"ref32","unstructured":"14% of Americans say they use CBD products. (2025). Accessed. 21 May 2025: https:\/\/news.gallup.com\/poll\/263147\/americans-say-cbd-products.aspx."},{"key":"ref33","unstructured":"Proportion of 16 to 59-year-old's in England and Wales reporting use of cannabis ever in their lifetime from 2001\/02 to 2023\/24. (2024). Accessed. 21 May 2025: https:\/\/www.statista.com\/statistics\/976850\/cannabis-use-in-the-uk\/."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting PF","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S, et al.. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015, 313:2456-73. 10.1001\/jama.2015.6358","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10389","article-title":"Cannabis and cannabinoids in the treatment of rheumatic diseases","volume":"11","author":"Gonen T","year":"2020","unstructured":"Gonen T, Amital H. Cannabis and cannabinoids in the treatment of rheumatic diseases. Rambam Maimonides Med J. 2020, 11:e0007. 10.5041\/RMMJ.10389","journal-title":"Rambam Maimonides Med J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10509","article-title":"Cannabis and rheumatoid arthritis: a scoping review evaluating the benefits, risks, and future research directions","volume":"14","author":"Paland N","year":"2023","unstructured":"Paland N, Hamza H, Pechkovsky A, Aswad M, Shagidov D, Louria-Hayon I. Cannabis and rheumatoid arthritis: a scoping review evaluating the benefits, risks, and future research directions. Rambam Maimonides Med J. 2023, 14:e0022. 10.5041\/RMMJ.10509","journal-title":"Rambam Maimonides Med J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei183","article-title":"Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis","volume":"45","author":"Blake DR","year":"2006","unstructured":"Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford). 2006, 45:50-2. 10.1093\/rheumatology\/kei183","journal-title":"Rheumatology (Oxford)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1089\/can.2019.0077","article-title":"Cannabis use and low-back pain: a systematic review","volume":"5","author":"First L","year":"2020","unstructured":"First L, Douglas W, Habibi B, Singh JR, Sein MT. Cannabis use and low-back pain: a systematic review. Cannabis Cannabinoid Res. 2020, 5:283-9. 10.1089\/can.2019.0077","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1177\/21925682211065411","article-title":"The efficacy of cannabis in reducing back pain: a systematic review","volume":"12","author":"Price RL","year":"2022","unstructured":"Price RL, Charlot KV, Frieler S, Dettori JR, Oskouian R, Chapman JR. The efficacy of cannabis in reducing back pain: a systematic review. Global Spine J. 2022, 12:343-52. 10.1177\/21925682211065411","journal-title":"Global Spine J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22727","article-title":"Efficacy, tolerability, and safety of cannabinoid treatments in the Rheumatic Diseases: a systematic review of randomized controlled trials","volume":"68","author":"Fitzcharles MA","year":"2016","unstructured":"Fitzcharles MA, Ste-Marie PA, H\u00e4user W, et al.. Efficacy, tolerability, and safety of cannabinoid treatments in the Rheumatic Diseases: a systematic review of randomized controlled trials. Arthritis Care Res (Hoboken). 2016, 68:681-8. 10.1002\/acr.22727","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1605","article-title":"The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial","volume":"24","author":"Almog S","year":"2020","unstructured":"Almog S, Aharon-Peretz J, Vulfsons S, et al.. The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial. Eur J Pain. 2020, 24:1505-16. 10.1002\/ejp.1605","journal-title":"Eur J Pain"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51014","article-title":"The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain","volume":"214","author":"Bebee B","year":"2021","unstructured":"Bebee B, Taylor DM, Bourke E, Pollack K, Foster L, Ching M, Wong A. The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain. Med J Aust. 2021, 214:370-5. 10.5694\/mja2.51014","journal-title":"Med J Aust"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.09.013","article-title":"Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial","volume":"112","author":"Berman JS","year":"2004","unstructured":"Berman JS, Symonds C, Birch R. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain. 2004, 112:299-306. 10.1016\/j.pain.2004.09.013","journal-title":"Pain"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39429.619653.80","article-title":"Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study","volume":"336","author":"Frank B","year":"2008","unstructured":"Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. BMJ. 2008, 336:199-201. 10.1136\/bmj.39429.619653.80","journal-title":"BMJ"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1757","article-title":"Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial","volume":"290","author":"Karst M","year":"2003","unstructured":"Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA. 2003, 290:1757-62. 10.1001\/jama.290.13.1757","journal-title":"JAMA"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.08.028","article-title":"Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial","volume":"133","author":"Nurmikko TJ","year":"2007","unstructured":"Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D. Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain. 2007, 133:210-20. 10.1016\/j.pain.2007.08.028","journal-title":"Pain"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0b013e3181f1c4ec","article-title":"Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study","volume":"89","author":"Rintala DH","year":"2010","unstructured":"Rintala DH, Fiess RN, Tan G, Holmes SA, Bruel BM. Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study. Am J Phys Med Rehabil. 2010, 89:840-8. 10.1097\/PHM.0b013e3181f1c4ec","journal-title":"Am J Phys Med Rehabil"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091414","article-title":"Smoked cannabis for chronic neuropathic pain: a randomized controlled trial","volume":"182","author":"Ware MA","year":"2010","unstructured":"Ware MA, Wang T, Shapiro S, et al.. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010, 182:E694-701. 10.1503\/cmaj.091414","journal-title":"CMAJ"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.12.010","article-title":"A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain","volume":"9","author":"Wilsey B","year":"2008","unstructured":"Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, Fishman S. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain. 2008, 9:506-21. 10.1016\/j.jpain.2007.12.010","journal-title":"J Pain"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low dose vaporized cannabis significantly improves neuropathic pain","volume":"14","author":"Wilsey B","year":"2012","unstructured":"Wilsey B, Marcotte TD, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2012, 14:136-48. 10.1016\/j.jpain.2012.10.009","journal-title":"J Pain"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2016.05.010","article-title":"An exploratory human laboratory experiment evaluating vaporized cannabis in the treatment of neuropathic pain from spinal cord injury and disease","volume":"17","author":"Wilsey B","year":"2016","unstructured":"Wilsey B, Marcotte TD, Deutsch R, Zhao H, Prasad H, Phan A. An exploratory human laboratory experiment evaluating vaporized cannabis in the treatment of neuropathic pain from spinal cord injury and disease. J Pain. 2016, 17:982-1000. 10.1016\/j.jpain.2016.05.010","journal-title":"J Pain"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001929","article-title":"Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials","volume":"162","author":"Fisher E","year":"2021","unstructured":"Fisher E, Moore RA, Fogarty AE, et al.. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain. 2021, 162:S45-66. 10.1097\/j.pain.0000000000001929","journal-title":"Pain"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin RH","year":"2008","unstructured":"Dworkin RH, Turk DC, Wyrwich KW, et al.. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008, 9:105-21. 10.1016\/j.jpain.2007.09.005","journal-title":"J Pain"},{"key":"ref54","unstructured":"Pain medication. time to stop - Doncaster CCG. (2023). Accessed: 21 May 2025: https:\/\/medicinesmanagement.doncasterccg.nhs.uk\/wp-content\/uploads\/2021\/06\/DCCG-Position-Statement-on-Opioid-Prescrib...."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009464.pub2","article-title":"Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy","volume":"2015","author":"Smith LA","year":"2015","unstructured":"Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev. 2015, 2015:CD009464. 10.1002\/14651858.CD009464.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref56","article-title":"Alternatives to opioids for managing pain","author":"Dey S","year":"2024","unstructured":"Dey S, Vrooman BM. Alternatives to opioids for managing pain. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref57","article-title":"","author":"Mack A","year":"2000","unstructured":"Mack A, Joy J. Marijuana as medicine? The science beyond the controversy.  National Academies Press,  Washington, DC; 2000. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK224384\/.."},{"key":"ref58","article-title":"Efficacy of cannabis-based medicines for pain management: A systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Aviram J","year":"2017","unstructured":"Aviram J, Samuelly-Leichtag G. Efficacy of cannabis-based medicines for pain management: A systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2017, 20:E755-96.","journal-title":"Pain Physician"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.2217\/nmt-2018-0050","article-title":"Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from randomized clinical trials","volume":"9","author":"Markov\u00e1 J","year":"2019","unstructured":"Markov\u00e1 J. Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from randomized clinical trials. Neurodegener Dis Manag. 2019, 9:9-13. 10.2217\/nmt-2018-0050","journal-title":"Neurodegener Dis Manag"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.7326\/M21-4520","article-title":"Cannabis-based products for chronic pain: a systematic review","volume":"175","author":"McDonagh MS","year":"2022","unstructured":"McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: a systematic review. Ann Intern Med. 2022, 175:1143-53. 10.7326\/M21-4520","journal-title":"Ann Intern Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060807","article-title":"Safety and efficacy of medical cannabis in fibromyalgia","volume":"8","author":"Sagy I","year":"2019","unstructured":"Sagy I, Bar-Lev Schleider L, Abu-Shakra M, Novack V. Safety and efficacy of medical cannabis in fibromyalgia. J Clin Med. 2019, 8:807. 10.3390\/jcm8060807","journal-title":"J Clin Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson JR","year":"2010","unstructured":"Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010, 39:167-79. 10.1016\/j.jpainsymman.2009.06.008","journal-title":"J Pain Symptom Manage"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1089\/can.2017.0012","article-title":"Cannabis as a substitute for opioid-based pain medication: patient self-report","volume":"2","author":"Reiman A","year":"2017","unstructured":"Reiman A, Welty M, Solomon P. Cannabis as a substitute for opioid-based pain medication: patient self-report. Cannabis Cannabinoid Res. 2017, 2:160-6. 10.1089\/can.2017.0012","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2012.684624","article-title":"Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain","volume":"44","author":"Lucas P","year":"2012","unstructured":"Lucas P. Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. J Psychoactive Drugs. 2012, 44:125-33. 10.1080\/02791072.2012.684624","journal-title":"J Psychoactive Drugs"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26206257","article-title":"Safety of medical cannabis in neuropathic chronic pain management","volume":"26","author":"Bennici A","year":"2021","unstructured":"Bennici A, Mannucci C, Calapai F, et al.. Safety of medical cannabis in neuropathic chronic pain management. Molecules. 2021, 26:6257. 10.3390\/molecules26206257","journal-title":"Molecules"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00065707","article-title":"Cannabis use and risk of lung cancer: a case-control study","volume":"31","author":"Aldington S","year":"2008","unstructured":"Aldington S, Harwood M, Cox B, et al.. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J. 2008, 31:280-6. 10.1183\/09031936.00065707","journal-title":"Eur Respir J"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.07.034","article-title":"Heavy cannabis use is associated with low bone mineral density and an increased risk of fractures","volume":"130","author":"Sophocleous A","year":"2017","unstructured":"Sophocleous A, Robertson R, Ferreira NB, McKenzie J, Fraser WD, Ralston SH. Heavy cannabis use is associated with low bone mineral density and an increased risk of fractures. Am J Med. 2017, 130:214-21. 10.1016\/j.amjmed.2016.07.034","journal-title":"Am J Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2179","article-title":"Systemic effects of smoking","volume":"131","author":"Yanbaeva DG","year":"2007","unstructured":"Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007, 131:1557-66. 10.1378\/chest.06-2179","journal-title":"Chest"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.178.2.101","article-title":"Pharmacology and effects of cannabis: a brief review","volume":"178","author":"Ashton CH","year":"2001","unstructured":"Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001, 178:101-6. 10.1192\/bjp.178.2.101","journal-title":"Br J Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/354641-the-efficacy-and-safety-of-use-of-cannabis-and-cannabinoid-products-for-pain-relief-in-orthopaedic-conditions-and-trauma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:51:24Z","timestamp":1751529084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/354641-the-efficacy-and-safety-of-use-of-cannabis-and-cannabinoid-products-for-pain-relief-in-orthopaedic-conditions-and-trauma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":69,"URL":"https:\/\/doi.org\/10.7759\/cureus.87208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}